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Abstract
Background: Fission yeast is one of the most commonly used model organisms for studying genetics. For selection
of desirable genotypes, antibiotic resistance cassettes are widely integrated into the genome near genes of interest.
In yeasts, this is achieved by PCR amplification of the cassette flanked by short homology sequences, which can be
incorporated by homology directed repair. However, the currently available cassettes all share the same tef promoter
and terminator sequences. It can therefore be challenging to perform multiple genetic modifications by PCR-based
targeting, as existing resistance cassettes in strains can be favored for recombination due to shared homology between
the cassettes.
Results: Here we have generated new selection cassettes that do not recombine with those traditionally used. We
achieved this by swapping the tef promoter and terminator sequences in the established antibiotic resistance MX6
cassette series for alternative promoters and/or terminators. The newly created selection cassettes did not recombine
with the tef-containing MX6 cassettes already present in the genome, allowing for sequential gene targeting using the
PCR-based method. In addition, we have generated a series of plasmids to facilitate the C-terminal tagging of genes with
desired epitopes. We also utilized the anti-selection gene HSV-TK, which results in cell death in strains grown on the drug
5-Fluoro-2’-deoxyuridine (FdU, Floxuridin or FUDR). By fusing an antibiotic resistance gene to HSV-TK, we were able to
select on the relevant antibiotic as well as counter-select on FdU media to confirm the desired genomic modification had
been made. We noted that the efficiency of the counter selection by FdU was enhanced by treatment with hydroxyurea.
However, a number of DNA replication checkpoint and homologous recombination mutants, including rad3Δ, cds1Δ,
rad54Δ and rad55Δ, exhibited sensitivity to FdU even though those strains did not carry the HSV-TK gene. To remove
counter-selectable markers, we introduced the Cre-loxP irreversible recombination method. Finally, utilizing the negative
selectable markers, we showed efficient induction of point mutations in an endogenous gene by a two-step
transformation method.
Conclusions: The plasmid constructs and techniques described here are invaluable tools for sequential gene targeting
and will simplify construction of fission yeast strains required for study.
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Background
Fission yeast Schizosaccharomyces pombe is a popular
model organism for fundamental biological research [1]. A
haploid life cycle along with efficient homologous recom-
bination system and simple reproductive processes make it
an excellent system to study genetics. In yeast, genes can be
deleted and replaced with selection markers readily, simply
by inducing homology directed repair with a selection cas-
sette amplified with primers that contain short, flanking se-
quences homologous to a target gene [2, 3]. A strain of
induced genotype can be isolated simply by plating trans-
formants onto corresponding selection plates. Generated
strains can be further crossed to isolate multiple genetic
alternations that can be selected for using combination of
appropriate markers.
In fission yeast, commonly used drug selection cassettes
are kanMX6, natMX6, hygMX6 (hphMX6) and bleMX6
[2, 4, 5]. These cassettes are composed of a promoter and
terminator from the fungus Ashbya gossypii and genes
conferring selectable resistance to G418 (geneticin or neo-
mycin), nourseothricin (ClonNat or Nat), hygromycin B
and bleomycin respectively. Auxotrophic gene cassettes,
such as ura4+ from S. pombe and LEU2 from Saccharomy-
ces cerevisiae have also been extensively used in fission
yeast [6, 7]. However, when using auxotrophic cassettes,
strains must have mutations in the corresponding en-
dogenous gene, which could affect cell metabolism, stress
response and cell growth. Thus, use of antibiotic resist-
ance markers has become standard for yeast organisms, as
the working strain does not require any particular auxo-
trophic genetic background. However, as these antibiotic
cassettes all share the same promoter and terminator se-
quences, it is difficult to perform sequential gene targeting
due to the shared homology [5]. This issue is usually
solved by genetic cross between two mutant strains. How-
ever, this strategy is not feasible for mutants dysfunctional
in mating, meiosis or germination. In some cases the mat-
ing is successful, but it is difficult to obtain desired geno-
type in the offspring if genetic distance is too close or if
desired genotypes are not associated with selectable
marker or not readily isolated by the marker. Importantly,
genetic crossing also mixes epigenetic status of genome.
For example, telomere length will change if strains harbor-
ing distinct mean length of telomeres are crossed. These
risks are avoidable when sequential gene targeting is
performed. Therefore, ura4+, arg3+ and his3+ and LEU2
cassettes are still used, as these auxotrophic markers con-
tain their own distinct promoters and terminators [6–9].
The recently developed genome editing technology,
CRISPR (Clustered regularly interspaced short palindromic
repeats) and Cas9 (CRISPR-associated protein-9 endo-
nuclease), has become available to use in fission yeast [10].
In this system, the Cas9 nuclease is targeted to specific re-
gions of genomic DNA by its CRISPR RNA component, a
so-called guide RNA that binds to the target DNA, result-
ing in Cas9-mediated DNA double-strand breaks (DSBs) at
the target genomic locus. This system does not require se-
lection cassettes, as cells confer constitutive DNA DSBs
until the target DNA sequence is lost or altered. Because a
selection cassette is not required, this method is ideal for
the sequential targeting of multiple genes/loci; in particular
for gene disruption and for introducing point mutations or
insertions using a designed DNA repair template. However,
although the CRISPR/Cas9 strategy is widely used for gen-
etic engineering in animals and humans, the use of this
method to mutate genes in fission yeast currently holds a
number of limitations. It is often necessary to design a
number of guide RNAs, which need to be cloned into a fis-
sion yeast CRISPR/Cas9 plasmid [10]. Target sequences
must be unique, 20 bases long, and are limited to loci up-
stream of a protospacer adjacent motif (−NGG for Cas9).
This means that the designed DNA repair template will re-
combine only at the DSB site, and the substitution of the
designed point mutation needs to be close to the DSB site
[11]. It is also noted that adenine and thymine rich se-
quences cannot be targeted. Hence, whereas gene disrup-
tion, single point mutations and insertions are relatively
straightforward for the CRISPR/Cas9 method, replacement
of a large genomic DNA region with the designed DNA
template, such as wide range multiple mutagenesis of the
whole gene sequence [12], is not feasible. Thus, traditional
homologous recombination-based genetic engineering re-
mains the most robust method to perform genetic manipu-
lations in fission yeast.
Here, we report optimization of the classical PCR-based
targeting method by modification of well-known MX6
markers, which enables sequential knock in/out genes of
interest. We also generated the C-terminal tagging vectors
for PCR-based gene targeting. In addition, we generated
counter selectable drug resistance markers by fusing the
herpes simplex virus thymidine kinase (HSV-TK) with anti-
biotic resistance genes. This can replace the traditionally
used counter-selectable ura4+ cassette. Furthermore, intro-
duction of irreversible mutant loxP (locus of X(cross)-over
P1) sites allows recycling of selection cassettes. Finally,
using the generated constructs, we report a reliable two-
step mutagenesis method, suitable for mutagenesis of
essential genes. Altogether, we have demonstrated innova-
tive techniques that address current difficulties in the
construction of required fission yeast strains.
Results and discussion
Cassettes for PCR-based sequential targeting
Although PCR-based gene targeting by drug selection
markers is the conventional approach, it is not efficient
if a transforming strain already contains other drug
selection markers. All MX6 cassettes share 300 bp of the
tef promoter and 200 bp of the tef terminator, which are
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significantly larger than the 80–100 bp sequences intro-
duced in primers to target genes of interest. Therefore,
there is a high chance of recombination between the
MX6 cassettes [5]. In order to overcome this problem,
CMVneo and CMVzeo cassettes (Life Technology) were
cloned to replace the MX6 cassette of the plasmid
pFA6a-kanMX6 [2]. Resulting plasmids, pFA6a-neoCV
and pFA6a-zeoCV, contain neomycin/kanamycin and
ZeocinTM resistant genes, respectively, flanked by the
cytomegalovirus promoter (Pcmv) and the simian virus
40 terminator (Tsv40) (Fig. 1a). These cassettes share
only 20 bases of the primer annealing sites with the
MX6 cassettes, which reduces the risk of unwanted re-
combination between selection markers. In addition, the
tef promoter in the natMX6 cassette, which provides re-
sistance to nourseothricin (Nat), was replaced with the
CMV promoter (Pcmv), resulting in the plasmid named
pFA6a-natCX. The tef terminator of the hygMX6 cas-
sette, which provides resistance to Hygromycin B (Hyg),
was replaced with either the Tsv40 terminator or the S.
cerevisiae LEU2 terminator (Tscleu2), resulting in the
plasmids named pFA6a-hygMV and pFA6a-hygML,
respectively (Fig. 1a). The zeoCV cassette acts as an
equivalent to bleMX6 [4], and provides resistance to
ZeocinTM, bleomycin and phleomycin (Fig. 1b). We
confirmed that replacement of the promoter or termin-
ator did not impair the function of the drug resistant
cassettes. Thus, the newly generated selection cassettes
can be used as an alternative to existing MX6 cassettes.
Using the generated cassettes, we tested if they could be
used for sequential gene deletion. Two genes, crb2+ and
rdh54+, were sequentially targeted in strains bearing both a
kanMX6 and natMX6 cassette. Crb2 is the fission yeast
ortholog of human 53BP1 [13], and Rdh54 is the equivalent
of Rad54, which is required for meiotic recombination [14].
To delete crb2+, the hygMV cassette was amplified by PCR
using the crb2 100 bp primer set (Table 1, crb2 top and
bot) and pFA6a-hygMV plasmid as a template. A strain
bearing both kanMX6 and natMX6 [h90 ura4-D18 taz1-
YFP:kanMX6 sid4-mCherry:natMX6 hht1-Cerulean:ura4+]
was transformed with the crb2::hygMV PCR fragment, and
the transformant colonies were selected for resistance to
hygromycin B (Hyg). The presence of kanMX6 and
natMX6 cassettes was determined by resistance to G418
a
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Fig. 1 Selection markers for sequential gene targeting. a Schematic representation of sequential targeting cassettes pFA6a-neoCV, pFA6a-zeoCV,
pFA6a-natCX, pFA6a-hygMV and pFA6a-hygML. The region used as a PCR template is shown. The 100 base Top (Tag) primer anneals to the left
end (pink arrowhead on the left) and Bot primer anneals to the right end to amplify indicated cassettes (pink arrowheads on the right). The 100
base primers used in this study are listed in Table 1. Cyan arrows represent diagnostic primers used for screening of correct targeting (Table 2).
Sequences of primers are shown in Table 2. Backbone vector region (pFA6a) encodes ampicillin resistant cassette and ColE1 bacteria replication
origin, and the cassettes were inserted between PacI and PmeI sites. Black box and black arrow in the cassette represent indicated promoter and
terminator, respectively. White box in neoCV and zeoCV indicates the em7 promoter for E. coli. The size of the cassette is shown on the left.
Transcription direction is toward left for neoCV and zeoCV cassettes and toward right for other cassettes. b Wild-type and rdh54Δ cells in which
the zeoCV cassette replaced rdh54 were cultured in YES rich media, normalised and serially diluted. Five microliter of diluted fractions were
spotted on YES (input) or YES containing 100 μg/ml of ZeocinTM and incubated at 32 °C for 3 days. Only cells containing the zeoCV cassette grew
on YES with Zeocin. Deletion of the rdh54 gene required for meiosis does not impair cell growth and mitotic DNA damage repair. c Cells carrying
kanMX6 or natMX6 cassettes were transformed with hygMV (Top) or hygMX6 (Bottom) and selected for on YES plates containing 100 μg/ml
hygromycin (Hyg). Eighteen and 31 colonies that were randomly picked for hygMV and hygMX6 transformations respectively, were re-streaked on
YES plates containing 100 μg/ml Hyg (Left panel). Cells were then replica-plated to YES plates containing 100 μg/ml Hyg plus either 100 μg/
ml G418 (Middle panel) or 100 μg/ml ClonNat (Nat) (Right panel). In case of hygMV transformation, all transformed cells retained resistance to
G418 and ClonNat, whereas in case of hygMX6, only seven out of 31 did
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and ClonNat (Nat), respectively. The hygMV cassette was
therefore successfully integrated into the genome without
recombining with the MX6 cassettes present, conferring
resistance to multiple antibiotics (Fig. 1c: hygMV panel).
Deletion of crb2 by hygMV was confirmed by diagnostic
PCR using a forward primer within the hygR gene and a re-
verse primer downstream of crb2 (for sequences see Table 2,
hyg F1400 and crb2 R280D). In contrast, transformation
with the crb2::hygMX6 PCR fragment resulted in replace-
ment of kanMX or natMX6 markers, assessed by gain of
sensitivity to G418 and Nat, respectively (Fig. 1c: hygMX6
panel). Next, the rdh54+ gene was deleted in a similar fash-
ion, using a rdh54::zeoCV fragment generated by PCR using
the rdh54 100 bp primer set and pFA6a-zeoCV plasmid as
a template. Like hygMV, zeoCV did not recombine with any
of existent marker cassettes (data not shown). The rdh54
deletion in the resulting strain [h90 ura4-D18 crb2::hygMV
rdh54::zeoCV taz1-YFP:kanMX6 sid4-mCherry:natMX6
hht1-Cerulean:ura4+] was confirmed by diagnostic PCR
using primers rdh54 R265D and zeo R115 (Table 2). We
also confirmed that neoCV, hygML and natCX did not
recombine with the MX6 cassettes (data not shown).
Therefore, we conclude that replacement of the tef pro-
moter and/or terminator sequences prevents recombin-
ation of newly introduced drug selection cassette with the
MX6 cassettes already existing in a strain.
HSV-TK chimera selection markers
Until recently, the ura4+ auxotrophic marker was the
only marker in the fission yeast system to be both select-
able and counter-selectable. Cells carrying ura4+ gene
can be eliminated by growing on media supplemented
with 5-Fluoroorotic acid (5-FOA), as Ura4 converts 5-
FOA to toxic fluorodeoxyuridine [7]. Alternatively, the
thymidine kinase from herpes simplex virus (HSV-TK,
or TK) is available for use as a negative selection marker
[15]. TK phosphorylates 5-Fluoro-2’-deoxyuridine (FdU,
Floxuridin or FUDR) to give 5-Fluoro-2’-deoxyuridine-5-
monophosphate (FdUMP). FdUMP blocks activity of
thymidylate synthase, resulting in inhibition of 2’-deox-
ythymidine-5-triphosphate (dTTP) synthesis, leading to
loss of the dTTP pool and cell death. Hence, strains ex-
pressing a TK cassette cannot grow in the presence of
FdU [15, 16]. Unlike the ura4+ cassette, the TK cassette
can be used with any genotype background. Although
fission yeast carrying the TK cassette are sensitive to
FdU, a positive selectable marker is also needed in order
to isolate cells carrying TK [15]. This issue was solved by
Table 1 One hundred base primers for PCR-based targeting
fragments used in this study
Name Sequence
crb2 Top CCCTGGTTAAATTTGTAGTTCTGACAATTG
TGAGGTATTTTAGATGTTTTCAATATTTTGT
TTGAAAGTTTAACAATATTCGGATCCCCG
GGTTAATTAA
crb2 Bot CTAAAATTAATAAAAAGCTAAATTAATGA
GAGTGAAACTCAGGGGGAGTTAGTAAAA
ATAACTATATCAAAAAACCAAAAGAATTC
GAGCTCGTTTAAAC
rdh54 Top ACTTGAACACCACACGTTCGGTCTCATA
GTATTGTTGAGTAAATAAACACAGTTAC
CAAAGAGAATTGAAACCTTACTTTCGGA
TCCCCGGGTTAATTAA
rdh54 Bot TGCTCATAGAGATTGCCCAGTATCGAAG
GCTTGCTCAAAAGCGTTGTTTCTAATGGG
CAAGGAAAAACCGCTTACGCCTCGAATT
CGAGCTCGTTTAAAC
tpz1 Tag CTCTGAGGCCTGTGAAATGTGTCGGCTTG
GGCTACCTCATGGATCATTCTTTGAGCTAT
TGCGAGATTGGAAAAAAATAGAGGAGTT
TCGAAACAAAAGCCGGATCCCCGGGTTA
ATTAA
tpz1 Bot TTGGTCCGTTGTAAGCCATTTCACTGTATGT
CTGTAACAGTTAACTTCCGTACTTAGTAAA
ATGTTAGTAAAAAAGGAAGATATGTGATA
CAGCAATTGAGAATTCGAGCTCGTTTAAAC
tpz1 Top ATCAACAGACTTCAGTCAGCACTGTTACT
TATTAAAAAAAGTTGATTTTTATATAAAA
GTTAGCTGCGTTAAACAGTGCACGGATC
CCCGGGTTAATTAA
Under line encodes annealing site for the template. Top primer contains CGGATCCC
CGGGTTAATTAA at the 3’ end and 80–100 base upstream sequence of the target
site at the 5’ end. Bot primer contains GAATTCGAGCTCGTTTAAAC at the 3’ end and
80–100 base downstream complement sequence of the target site at the 5’ end
Table 2 Primers for diagnostic PCR
Name Sequence
neo R24 GTGCAATCCATCTTGTTCAATC
neo F630 TTTCTGGATTCATCGACTGTGG
zeo R115 CGAAGTCGTCCTCCACGAAG
zeo F134 ACGTGACCCTGTTCATCAGC
nat F900 GGGGTTCACCCTCTGCGGCC
nat R400 GGGACACTGGTGCGGTACCG
hyg F1400 CCGTCTGGACCGATGGCTGT
hyg R400 CTTCTCGACAGACGTCGCGG
kan F800 GGATTCAGTCGTCACTCATGGTG
kan R276 ATGCATCATCAGGAGTACGG
TK F1040 TACCGACGATCTGCGACCTG
TK R90 ACTTCCGTGGCTTCTTGCTG
adh1 R540U AGGAATACGGATACGATGGAG
Ptef R81 ACATGGGGATGTATGGGCTA
Ttef F1 CAGTACTGACAATAAAAAGATTCTTG
crb2 R280D CAACCATTCGAAACCTGCTAC
rdh54 R265D GAAAGCCAGAAACAGACAAGC
tpz1 F842U GGTAGTAGGCTAAATGTGAGTTG
tpz1 R400D CCCTTAGAAGATAAGCTCAACC
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a fusion of the TK gene with a positive selectable marker
in mammalian systems [17, 18].
We decided to create fused selection markers for fission
yeast, which express fusion antibiotic resistance genes with
the TK gene that serve for both positive and negative selec-
tion by chemical treatments. We first inserted the TK gene
upstream of the gene coding sequences in kanMX6 and
natMX6, giving TKanMX6 and TKnatMX6. To assess
function of the fusion genes, the TK-fusion cassettes were
inserted at the leu1+ locus. As expected, cells carrying
TKanMX6 and TKnatMX6 were resistant to G418 and
Nat, respectively. However, these cells grew in the presence
of 100 μg/ml FdU, suggesting that the fused TK gene is not
functional (see the TKnatMX6 in Fig. 2b). We speculated
that the level of TK, expressed by the tef promoter, was not
sufficient to convert FdU for a toxic amount of FdUMP, as
previously published the TK cassette for fission yeast uses
the stronger adh1 promoter [15]. We therefore replaced
the tef promoter with a stronger CMV promoter (giving
TKnatCX, Fig. 2a), which indeed enhanced cells sensitivity
to FdU (Fig. 2b). Furthermore, an even greater sensitivity
was obtained with replacement of the S. pombe adh1
a
natRPadh1 TtefHSV-TK
kanRPadh1 TtefHSV-TK
Padh1 TtefHSV-TKhygR
TKnatAX
TKanAX
HyTKAX
2.7kb
2.8kb
3.1kb
b
WT
TKnatMX6
TKnatCX
TKnatAX
natMX6
WT
TKanAX
neoCV
kanMX6
c
WT
HyTKAX
hygMX6
input FdU 20 µg/ml FdU 100 µg/ml Nat 100 µg/ml
input FdU 20 µg/ml FdU 100 µg/ml G418 100 µg/ml
input FdU 20 µg/ml FdU 100 µg/ml Hyg 100 µg/ml
d
nat F900
kan F800
Cells
adh1 R540U
TK F1040
TK F1040TK R90
Fig. 2 TK-fusion counter-selectable cassettes. a Schematic representation of counter-selectable cassettes HyTKAX, TKanAX and TKnatAX. Region
used as a PCR template is shown. The backbone vector is pFA6a and the cassettes were inserted between PacI PmeI sites. Top primers anneal to
the left end (pink arrowhead on the left) and Bot primer anneals to the right end to amplify indicated cassettes (pink arrowheads on the right). Cyan
arrows represent diagnostic primers used for screening of correct targeting, and sequence of primers is shown in Table 2. The TK fusion genes are
transcribed by the S. pombe adh1 promoter and terminated at the tef terminator. The size of the cassette is shown on the left. Transcription
direction is toward right. b, c and d FdU sensitivity of cells carrying the HSV-TK fusion cassettes. Indicated cells were cultured in YES rich media,
normalised and sequentially diluted five times. Five microliter of diluted fractions were spotted on YES containing the indicated drugs and
incubated at 32 °C for 3 days. b Cells carrying the TKnatAX cassette are hyper sensitive to 20 μl/ml FdU. c Cells carrying the TKanAX cassette are
sensitive to 100 μl/ml FdU. d Cells carrying the HyTKAX cassette are sensitive to 20–100 μl/ml FdU
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promoter, giving TKnatAX (Fig. 2a and b). The success of
this finding was reiterated with the TK-kanR fusion gene,
giving TKanAX (Fig. 2a). Cells carrying TKanAX were fully
resistant to G418 and displayed an intermediate sensitivity
to FdU (Fig. 2c). Finally, HSV-TK was inserted after the
hygR gene coding sequence, similar to the HyTK or HygR-
TK fusion genes used in mammalian systems [17], giving
HyTKAX (Fig. 2a). Cells carrying HyTKAX were resistant
to hygromycin B and sensitive to FdU (Fig. 2d). In conclu-
sion, fusions of the yeast antibiotic markers with the TK
gene are functional, allowing both positive and negative se-
lections of cells carrying the fusion cassettes.
In yeast, low sensitivity to FdU is partially caused by poor
uptake of thymidine. This problem can be overcome by ec-
topic expression of human equilibrative nucleoside trans-
porter (ENT), which is highly efficient at the uptake of
thymidine analogs [19]. However, this strategy requires cells
to carry the ENT expression cassette. Toxicity of FdU in
the presence of TK is caused by impaired deoxythymidine-
5-monophosphate (dTMP) synthesis and reduced dTTP
levels [16]. Hence, we anticipated that reduction of the
deoxynucleotide (dNTP) pool by hydroxyurea (HU) might
further reduce the dTTP level, leading to increased sensitiv-
ity to FdU. To test this possibility, cells carrying TKnatAX,
TKanAX and HyTKAX were spotted on YES media con-
taining increasing concentrations of HU (1, 2.5 and 5 mM)
along with 100 μg/ml FdU (Fig. 3). The growth of cells
carrying TKanAX was significantly suppressed by FdU in
the presence of HU, as represented by microcolonies. Taken
together, we recommend the following concentrations for
FdU anti-selections: 20 μg/ml FdU for TKnatAX, 100 μg/ml
FdU for HyTKAX and 100 μg/ml FdU plus 5 mM
HU for TKanAX.
Mutants defective in DNA replication checkpoint and
homologous recombination are sensitive to FdU
Although the TK cassette is a useful tool, we have come
across a number of fission yeast mutants that exhibited
sensitivity to FdU while not containing the TK cassette.
Specifically, our data suggest that mutants defective in
DNA replication and DNA damage response pathways are
sensitive to FdU. It has previously been reported that
rad3Δ cells, which lack the DNA damage checkpoint pro-
tein Rad3 (a fission yeast ATR homolog [20]), are sensitive
to the deoxythymidine variant, 5’-Ethyl-2’-deoxyuridine in
the presence of TK [21]. Surprisingly, we identified that
rad3Δ cells that did not express TK were also sensitive to
20 μg/ml FdU (Fig. 4a). In response to DNA damage and
DNA replication problems, Rad3 activates Chk1 and Cds1,
respectively [20]. Interestingly, cds1Δ cells were sensitive to
100 μg/ml FdU, whereas chk1Δ cells were only mildly sensi-
tive to FdU (Fig. 4b). Moreover, homologous recombination
repair mutant rad54Δ cells also exhibited sensitivity to
100 μg/ml FdU (Fig. 4b). Whilst Rad54 is essential for hom-
ologous recombination, the Rad55-Rad57 complex acts in
parallel to Swi5-Sfr1 and upstream of Rad54 [22]. As such,
rad55Δ cells exhibited only mild sensitivity. Although it re-
mains unclear how FdU can be converted to FdUMP under
DNA replication stress, our data suggest that mutants de-
fective in DNA replication and DNA damage response
pathways are sensitive to FdU. Therefore, we recommend
to test working strains for the sensitivity to FdU prior to
performing counter-selection screening.
The Cre/loxP system can be utilized for the recycling of
counter-selectable markers
Another way to address the limited availability of selection
markers is to recycle the cassette using the Cre/loxP
approach [23–25]. In this system, Cre recombinase recom-
bines two short loxP sequence sites to generate crossover
products. Hence, a loxP-flanked (floxed) gene of interest or
selection marker can be deleted via expression of Cre
recombinase. To generate conditional pop-out markers for
TKanAX, TKnatAX and HyTKAX, mutant variants of loxP
sequences - lox71 and lox66 - were introduced at the start
and end of the cassettes. Resulting cassettes were named
WT
TKnatAX
HyTKAX
TKanAX
no HU 1 mM HU 2.5 mM HU 5 mM HU
WT
TKnatAX
HyTKAX
TKanAX
F
dU
 100 µg/m
l
no F
dU
Fig. 3 Concomitant treatment with HU enhances sensitivity to FdU. Indicated cells were cultured in YES, normalised and serially diluted five times
with YES. Five microliter of diluted fractions were spotted on rich media containing the indicated drugs and incubated at 32 °C for 3 days. Cells
carrying TKanAX grew poorly in YES containing 5 mM HU and 100 μg/ml FdU
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FTKanAX, FTKnatAX and FHyTKAX, respectively (Fig. 5a,
Table 3). Although the lox71 and lox66 sequences are
substrates for Cre recombinase, the crossover results in the
generation of wild type loxP and double mutated loxP
sequences; the latter is no longer recognized by the recom-
binase [26]. Therefore, the scar of a lox71-lox66 recom-
bined site will not crossover with a newly introduced loxP-
containing marker in the genome.
We also generated a series of the Cre expression vectors,
encoding a fusion protein, comprised of the three tandem
hemagglutinin (HA) genes, a nuclear localization signal
(nls) sequence and Cre recombinase (3xHA-nls-Cre), under
the control of a CMV promoter (Fig. 5b). To maximize
versatility, the Cre expression vector carries a series of the
selection markers; kanMX6, TKkanAX, hygMX6, HyTKAX,
natMX6, TKnatAX or the aurR cassette, which encodes
gene resistance to aureobasidin A [27], as well as
auxotrophic markers, including ura4+, arg3+, leu1+ and
ade6+ (Table 4). Altogether, a choice of three ‘floxed’
markers and a series of the Cre expression vectors would
maximize the utility for genome engineering.
Using the Cre expression vector, the efficiency of the
FTKnatAX cassette removal was assessed. Cells carrying
the FTKnatAX cassette were transformed with the Cre
expression vector, and were directly plated on FdU plates.
Total 162 colonies were formed on the FdU plate after
Cre expression, and all were lost the resistance to Nat.
Ten clones were randomly selected and their loss of the
FTKnatAX cassette was confirmed by PCR. Thus, FdU
counter selection along with Cre expression efficiently
eliminates cells retaining the FTKnatAX Cassette.
Tandem epitopes C-terminal tagging plasmids, pNX3 series
In addition to creating a series of plasmids useful for the
sequential modification of genes, we have also created
similar plasmids for C-terminal tagging of gene products.
Tandem repeats of epitope tags enhance the detection
efficiency of target proteins, which is important for their
visualization, especially if they have low-abundance. How-
ever, larger tags can potentially interfere with protein
function. Therefore, the size of the tag needs to be opti-
mized for each protein of interest. To address this, three
tandem genes coding for either HA, PK (V5) and FLAG
epitopes, flanked by NheI and XbaI restriction sites were
synthesized, and cloned between PacI and AscI sites of the
pFA6a-kanMX6 C-terminal tagging plasmid [2] (Fig. 6a
a
b
Fig. 4 rad3Δ, cds1Δ and rad54Δ are sensitive to FdU. Indicated cells were cultured in YES, normalised and 5 times sequentially diluted with YES. Five
microliter of diluted fractions were spotted on rich media containing the indicated drugs and incubated at 32 °C for 3 days. a rad3Δ cells are hyper
sensitive to 20 μg/ml FdU. b cds1Δ and rad54Δ cells are sensitive to 100 μg/ml FdU. chk1Δ and rad55Δ cells are mildly but significantly sensitive to FdU,
compared to wild type cells
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and b). PCR-based amplification of the C-terminal tagging
plasmid for gene targeting results in addition of a peptide
- Arg-Ile-Pro-Gly-Leu-Ile-Asn-Ala-Ser - which acts as a
linker between the target protein and the epitopes
(Fig. 6A). The resulting plasmids were named pNX3 (plas-
mid NheI-XbaI version three).
The pNX3 plasmid series was extended by replacing
kanMX6 with other drug resistance cassettes [hygMX6,
natMX6, neoCV, hygML, natCX and zeoCV] or ura4+ cas-
sette. The cleavage site of NheI is compatible with that of
XbaI, which allows ligation of epitope tags. For example,
3xPK can be sequentially subcloned to generate 6xPK,
9xPK and 12xPK-tagging plasmids. A list of the pNX3
plasmid series created is shown in Table 5. All plasmids
were verified by DNA sequencing, and some of the con-
structs have been used elsewhere [12, 28].
Using PK-tagging plasmids from this series and the tpz1
Tag and Bot 100 base primer set, we successfully inserted
the gene encoding three, six, nine and 12 tandem-repeats
of the PK epitope at the end of the coding gene of tpz1+ to
endogenously express Tpz1 with the PK tagged at the C-
terminus (Fig. 6c). Tpz1 is a component of telomere shel-
terin complex and is a homolog of human TPP1. Tpz1
both positively and negatively regulates telomere length by
interacting with different factors [28, 29]. One interacting
partner binds to the C-terminal ends of Tpz1, which is
required for formation of shelterin to suppress telomere
elongation [29–31]. Deletion of tpz1 leads to telomere
deprotection and cell death [31]. As expected, the
efficiency of detection of Tpz1 was increased with a num-
ber of PK repeats, and the observed difference in band
sizes was due to a different number of 3xPK repeats in
each sample (molecular weight of the 3xPK is 4.2 kDa).
The slower migrating band in each lane, that presumably
corresponds to SUMOylated Tpz1 [32], also became
readily detectable (Fig. 6c). To determine whether the
C-terminal fusion of PK-tags impaired the activity of Tpz1,
Table 3 The targeting cassette vectors
Name Promoter/gene/terminator Selection/counter
pFA6a-kanMX6 Ptef/kanR/Ttef G418
pFA6a-neoCV Pcmv/neoR/Tsv40 G418
pFA6a-zeoCV Pcmv/zeoR/Tsv40 Zeocin
pFA6a-hygMX6 Ptef/hph/Ttef G418
pFA6a-hygMV Ptef/hph/Tsv40 Hygromycin B
pFA6a-hygML Ptef/hph/Tscleu2 Hygromycin B
pFA6a-natMX6 Ptef/natR/Ttef ClonNat
pFA6a-natCX Pcmv/natR/Ttef ClonNat
pFA6a-TKnatCX Pcmv/TK-natR/Ttef ClonNat/FdU
pFA6a-TKnatAX Padh/TK-natR/Ttef ClonNat/FdU
pFA6a-TKanAX Padh/TK-kanR/Ttef G418/FdU + HU
pFA6a-HyTKAX Padh/hph-TK/Ttef Hygromycin B/FdU
pFA6a-FTKnatAX lox71-Padh/TK-natR/Ttef-lox66 ClonNat/FdU
pFA6a-FTKanAX lox71-Padh/TK-kanR/Ttef-lox66 G418/FdU + HU
pFA6a-FHyTKAX lox71-Padh/hph-TK/Ttef-lox66 Hygromycin B/FdU
b
EcoRI
PmeIBglII
AvrII
AscIEcoO109I
XhoI, SalI, XmaI,
PacI,NheI
ampR ars1
kanR TtefPtef
Tscadh1
cre
NLS
3xHA
Pcmv
a
natRPadh1 TtefHSV-TK
lox71 lox66
FTKnatAX
kanRPadh1 TtefHSV-TK
lox71 lox66
FTKanAX
Padh1 TtefHSV-TKhygR
lox71 lox66
FHyTKAX
Fig. 5 Cre expression vector and loxP cassette. a Schematic representation of loxP-flanked (floxed) TK-fusion cassettes FHyTKAX, FTKanAX and FTKnatAX.
Region used as a PCR template is shown. Forward direction of lox71 and lox66 sequences are inserted into the TK cassettes shown in Fig. 2a. b Schematic
representation of pNXRVa-HACre. Fusion protein of three tandem HA epitope tag, NLS (nuclear localization signal) and Cre recombinase is expressed by
the constitutively active CMV promoter. kanMX6 is inserted between BglII and PmeI sites. The genomic DNA fragment containing the early replication origin
ARS1 is inserted downstream of the kanMX6 cassette. A number of unique restriction enzyme sites are indicated
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we measured telomere length of cells bearing Tpz1 fused
to a different number of repeats of PK epitopes (Fig. 6d).
Whereas three and six tandem PK tags did not affect
telomere length homeostasis, nine tandem PK tags led to
slightly elongated telomeres. Thus, we conclude that,
although larger tags make proteins and their modifications
more visible, they may increase the risk of interfering with
function.
Two-step transformation for gene editing at the
endogenous locus
A traditional two-step method can utilize the ura4+
cassette to introduce point mutations [7]. First, the gene
of interest is replaced by the ura4+ cassette in a strain
where the endogenous ura4+ gene region has been
deleted (ura4-D18). Next, the inserted ura4+ cassette is
replaced with the mutagenized gene allele. The success-
fully transformed cells, which lost ura4+, are initially
selected using 5-FOA. We previously utilized this
method with success to mutagenize the rap1 gene [12].
This strategy requires the ura4-D18 mutation in the
strain and further epitope tagging may be necessary to
determine the stability of the mutant product down-
stream. To mutagenize essential genes, a diploid strain
should be used in which only one allele of the target
gene is replaced with the ura4+ cassette. However,
because the wild type allele has better homology, the
targeting construct favors the wild type allele over the
deleted allele. Thus, although treatment with 5-FOA can
reduce occurrence of false positives, the presence of the
wild type allele makes difficult to target the ura4+
replaced locus in diploid cells.
To address this issue, we propose a new method,
which utilizes anti-selection markers. In this method, the
gene of interest is replaced with a negative selection
cassette from the TK-fusion series. The second step uses
a plasmid from the pNX3 series to introduce the desired
modification to the gene. Briefly, the gene of interest to-
gether with its endogenous promoter is subcloned into a
pNX3 plasmid and mutagenized as desired. The TK-
fusion cassettes contain the tef terminator but not the tef
promoter. The shared homology between the tef
terminator and the promoter region of the gene in the
pNX3 plasmid and the TKnat/kan cassettes permits
insertion of the modified gene at the deleted allele via
homology directed repair.
As an example, we utilized this method to introduce
point mutations in the tpz1+ gene. As tpz1+ is essential
gene, we first deleted one tpz1 allele in a diploid strain
using the PCR-based TKnatCX recombination method
(Fig. 7a). The cloned tpz1+ in the pNX3a-3HA plasmid
(pNX3a-tpz1-HA3) was mutagenized at the position
c.322–323 to give the mutation K75A. The resulting con-
struct, pNX3a-tpz1-K75A-HA3, was digested with the re-
striction enzymes, and the tpz1 heterozygous diploid strain
was transformed with this targeting construct (Fig. 7b). The
resulting transformants were selected by G418 resistance.
Most of the positive colonies lost their Nat resistance as
successful insertion of the mutant gene would result in
removal of the TKnatCX cassette. In our experience, suc-
cess rate of the gene replacement was 96 % (25 cells lost
the Nat resistance out of 26 cells resistant to G418). Diag-
nostic PCR using primer sets shown in Fig. 7c confirmed
that all of the transfomants that lost Nat resistance had the
correct replacement of tpz1(K75A)-3xHA:kanMX6 at the
TKnatCM site. Expression of Tpz1(K75A)-3xHA was con-
firmed by Western blot. Finally, the resulting heterozygous
diploid strain (h−/h+ ade6-M210/M216 tpz1(K75A)-3xHA:-
kanMX6/+) was starved to induce sporulation, and the off-
spring was selected on the G418 to isolate a tpz1(K75A)
haploid strain. Expression level, function of Tpz1(K75A),
and the phenotype of this mutant strain were reported
previously [28]. Therefore we showed that this method can
be successfully and reliably used to target and modify genes
to give stable products.
Conclusions
We have demonstrated that the replacement of promoter
and/or terminator sequences in drug resistance cassettes
can eliminate the need to replace existing markers in work-
ing strains. This enables sequential genetic manipulations
to be performed without making changes to the genetic
and epigenetic background of strains. In addition, we have
shown that the TK-fusion markers can be used to replace
genes and subsequently swapped in order to counter-select
for undesirable genotypes. While PCR-based gene targeting
remains a powerful and cost-effective method, the modified
plasmids and optimized techniques presented in this study
would enable researchers to perform their desired genetic
manipulations more efficiently and reliably.
Table 4 The Cre-expression vectors
Name Marker cassette Selection
pNXRVa-HACre kanMX6 G418
pNXRVat-HACre TKanAX G418
pNXRVb-HACre hygMX6 Hygromycin B
pNXRVbt-HACre HyTKAX Hygromycin B
pNXRVc-HACre natMX6 ClonNat
pNXRVct-HACre TKnatAX ClonNat
pNXRVd-HACre ura4+ -uracil
pNXRVg-HACre arg3+ -arginine
pNXRVh-HACre leu1+ -leucin
pNXRVj-HACre aur1R Aureobasidin A
pNXRVk-HACre ade6
+
-adenine
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Methods
Yeast media
All media and supplements were purchased from FOR-
MEDIUM™. Fission yeast were grown at 32 °C.
Plasmid constructions
All plasmids generated are listed in Tables 3, 4 and 5 and
are available from Addgene (www.addgene.com). Oligos
used for cloning are listed in Table 6. To create pFA6a-
a
b c d
Fig. 6 The COOH-terminus tagging plasmid. a Schematic representation of pNX3a-HA3 and sequence of three tandem HA and multi cloning sites. The
HA encoding gene is inserted between PacI AscI sites. The 100 base Tag primer anneals to the left end (pink arrowhead on the left in plasmid image and
long arrow in HA3 sequence) and Bot primer anneals to the right end to amplify indicated cassettes (pink arrowheads on the right in plasmid image). A
number of unique restriction enzyme sites are indicated. b Sequence of three tandem PK (top) and FLAG (bottom) fragments. pNX3a-PK3 and pNX3a-FL3
plasmids were generated by replacing HA3 sequence between NheI and XbaI sites in pNX3a-HA3 (a) with indicated PK and FLAG sequences, respectively.
c Detection efficiency of PK-tagged Tpz1. Western blot shows detection of PK epitope fused Tpz1. No obvious non-specific bands were detected. Proteins
were extracted from cells and subjected to SDS-PAGE. Anti-V5 antibody (AbD Serotec) was used to detect PK fused Tpz1 protein. Anti-Cdc2 antibody
(anti-PSTAIRE) (Santa Cruz) was used as a control for loading. d Telomere length homeostasis is slightly impaired with the nine tandem PK tagging of Tpz1.
Genomic DNA was harvested from cells cultured over 2 weeks after generation of strains, and digested with EcoRI and separated in 1 % agarose gel.
Telomere containing fragments were detected with the synthetic telomeric DNA probe
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neoCV and pFA6a-zeoCV plasmids, the CMVneo and
CMVzeo cassettes were amplified from pCMVneo and
pCMVzeo plasmids, respectively, using primers Pcmv top-
PmeI and Tsv40 bqt-BglII. The kanMX6 cassette of pFA6a-
kanMX6 was digested with BglII and PmeI and replaced
with the CMVneo and CMVzeo cassettes. To create pFA6a-
natCX, the CMV promoter was amplified from pCMVpuro
plasmid using primers Pcmv top-BglII and Tsv40 bot-PmeI,
and the tef promoter of the natMX6 cassette in pFA6a-
natMX6 was digested with BglII and NcoI (blunt ended)
and replaced by BglII and KpnI digested (blunt ended)
Pcmv PCR fragment. To create pFA6a-hygMV, the termin-
ator of the sv40 was subcloned from pSV2-hyg plasmid.
pSV2-hyg was digested with PfMI and HpaI and self-
ligated to remove the gene encoding large tumor antigen,
and the hyg resistant gene with Tsv40 was cloned using
primers, HygR top-HindIII and Tsv40 bot-PmeI. The tef ter-
minator along with a part of the hyg resistant gene of
pFA6a-hygMX6 was replaced with the hygR–Tsv40 PCR
product using SacII and PmeI sites, and resulting plasmid
was named pFA6a-hygMV. To replace the terminator of
the hygMX6 cassette with the S. cerevisiae LEU2 gene, the
terminator of LEU2 was cloned from the S. cerevisiae gen-
omic DNA using primers, Tscleu2 top-ClaI-PstI, and
Tscleu2 bot-PmeI, and inserted between PstI and ClaI sites
of pFA6a. The tef promoter and the hyg resistant gene were
cloned using primers, Amp rev and Hyg bot-NheI-ClaI, and
inserted at BglII-ClaI sites of pFA6a. The resulting plasmid
pFA6a-Ptef-hyg was digested with ClaI and the LEU2 ter-
minator was inserted to generate pFA6a-hygML.
To create pFA6a-TKanMX6 and pFA6a-TKnatMX6, the
TK gene was cloned using primers, HSVtk top-SpeI-NcoI-
HindIII and HSVtk bot-XmaI-NcoI, digested and inserted at
NcoI site of pFA6a-kanMX6 and pFA6a-natMX6. To create
pFA6a-HyTKMX6, the TK PCR product was digested with
NcoI and XmaI (blunt ended) and replaced natR gene of
pFA6a-natMX6 using NcoI and SphI (blunt ended) sites.
The resulting plasmid was named pFA6a-HSVTKMX6.
pFA6a-hygML was digested with NheI and PmeI, and
Tscleu2 was replaced with the SpeI and PmeI digested HSV-
TK-Ttef fragment from pFA6a-HSVTKMX6. To create
pFA6a-TKnatCX, the CMV promoter was cloned from
pCMVzeo using primers Pcmv top-BglII and zeo R115 and
digested with BglII and MscI. TKnatMX6 was digested with
BglII and SpeI (blunt ended), and the tef promoter was re-
placed with the CMV promoter.
The adh1 promoter was amplified from S. pombe gen-
omic DNA using primers, Padh1 top-PmeI and bot-Hin-
dIII-NheI, and cloned into pJET vector (ThermoFisher).
pJET-Padh1 was digested with PmeI and ClaI (within
pJET), and the natCM cassette of pFA6a-natCM was re-
placed with Padh1 using NruI and ClaI digest to generate
pFA6a-Padh1. To create pFA6a-TKanAX and pFA6a-
TKnatAX, pFA6a-TKanMX6 and pFA6a-TKnatMX6 were
Table 5 The C-terminal tagging vectors, pNX3 series
Name Epitope tag Marker cassette Selection
pNX3a-PK3 3xPK kanMX6 G418
pNX3a-PK6 6xPK kanMX6 G418
pNX3a-PK9 9xPK kanMX6 G418
pNX3a-PK12 12xPK kanMX6 G418
pNX3a-FL3 3xFlag kanMX6 G418
pNX3a-HA3 3xHA kanMX6 G418
pNX3a-Myc13 13xMyc kanMX6 G418
pNX3b-PK3 3xPK hygMX6 Hygromycin B
pNX3b-PK6 6xPK hygMX6 Hygromycin B
pNX3b-PK9 9xPK hygMX6 Hygromycin B
pNX3b-PK12 12xPK hygMX6 Hygromycin B
pNX3b-FL3 3xFlag hygMX6 Hygromycin B
pNX3b-HA3 3xHA hygMX6 Hygromycin B
pNX3b-Myc13 13xMyc hygMX6 Hygromycin B
pNX3c-PK3 3xPK natMX6 CloneNat
pNX3c-PK6 6xPK natMX6 CloneNat
pNX3c-PK9 9xPK natMX6 CloneNat
pNX3c-PK12 12xPK natMX6 CloneNat
pNX3c-FL3 3xFlag natMX6 CloneNat
pNX3c-HA3 3xHA natMX6 CloneNat
pNX3c-Myc13 13xMyc natMX6 CloneNat
pNX3d-PK3 3xPK ura4+ -uracil
pNX3d-PK6 6xPK ura4+ -uracil
pNX3d-PK9 9xPK ura4+ -uracil
pNX3d-PK12 12xPK ura4+ -uracil
pNX3d-FL3 3xFlag ura4+ -uracil
pNX3d-HA3 3xHA ura4+ -uracil
pNX3d-Myc13 13xMyc ura4+ -uracil
pNX3a2-PK3 3xPK neoCV (rev) G418
pNX3a2-FL3 3xFlag neoCV (rev) G418
pNX3a2-HA3 3xHA neoCV (rev) G418
pNX3a2-Myc13 13xMyc neoCV (rev) G418
pNX3b2-PK3 3xPK hygML Hygromycin B
pNX3b2-FL3 3xFlag hygML Hygromycin B
pNX3b2-HA3 3xHA hygML Hygromycin B
pNX3b2-Myc13 13xMyc hygML Hygromycin B
pNX3c2-PK3 3xPK natCX CloneNat
pNX3c2-HA3 3xHA natCX CloneNat
pNX3c2-Myc13 13xMyc natCX CloneNat
pNX3s2-PK3 3xPK zeoCV (rev) Zeocin
pNX3s2-FL3 3xFlag zeoCV (rev) Zeocin
pNX3s2-HA3 3xHA zeoCV (rev) Zeocin
pNX3s2-Myc13 13xMyc zeoCV (rev) Zeocin
(rev): neoCV and zeoCV cassettes are inserted in reverse direction
Amelina et al. BMC Biotechnology  (2016) 16:76 Page 11 of 15
digested with SpeI, and the TKan and TKnat genes were
inserted at SpeI site of pFA6a-Padh1 in forward direction.
To create pFA6a-HyTKAX, the HyTK-Ttef fragment was
amplified from pFA6a-HyTKMX6 using primers, Hyg top-
HindIII and 100 bp-bot, and cloned into pFA6a between
HindIII and PmeI sites, and Padh1 from pFA6a-Padh1 was
inserted at HindIII site in forward direction.
The Cre expression plasmid was created as follows. The
CMV promoter was isolated from pAUR224 (TAKARA/
Clontech) using Tsp45I (blunt ended) and HindIII, and
was inserted at NdeI (blunt ended) and HindIII site of
pFA6a-13xmyc-hygMX6. The three tandem HA epitope
encoding DNA fragments (3xHA) were synthesized by an-
nealing of oligos, 3xHA top and bot, followed by DNA
polymerase reaction. The 3xHA DNA fragment was gen-
erated by digest with PacI and AscI and replaced 13xmyc
gene. The Cre recombinase encoding gene was cloned
using primer nls-Cre top-XbaI that includes sv40 nuclear
localization signal (NLS) at 5’ linker and Cre bot-XbaI,
and was digested and inserted at XbaI site downstream of
3xHA. The resulting plasmid carried the cassette express-
ing 3xHA-nls-Cre from the CMV promoter and was
named pNXVa-HA3nlsCre. The DNA fragment contain-
ing the S. pombe replication origin, ars1, was isolated by
AvrII digest of the S. pombe plasmid pKAN1. pFA6a-
kanMX6 was digested with EcoRI and SapI, and the ars1
containing AvrII fragment was inserted following blunt
ending of the cleaved sites. The resulting plasmid that
carried kanMX6 and ARS1 was named pNXRa. The Cre
expression cassette was isolated by EcoO109I and BglII
digest and inserted into pNXRa to generate pNXRVa-
HA3nlsCre.
Ptpz1 Ttpz1tpz1+
Tscadh1
kanR TtefPtef
3xHA
tpz1 mutant
natRPcmv HSV-TK Ttef Ttpz1Ptpz1
PmeIPvuII
b
Ptpz1 Ttpz1tpz1+
Ptpz1 Ttpz1tpz1+
natRPcmv HSV-TK Ttef
TPZ1 Top TPZ1 Bota
c
Ptpz1 Ttpz1tpz1+
Ttpz1kanR TtefPteftpz1mutantPtpz1
kan F800Ptef R81 kan R276 tpz1 R400D
tpz1 R400D
tpz1 F842U
tpz1 F842U
tpz1 F800U tpz1 R1745
tpz1 R400D
nat F900
Fig. 7 Two-step mutagenesis. Schematic diagram of the two-step gene replacements and induction of point mutation of the tpz1 gene. List of
diagnostic primers is shown in Table 2. a PCR based tpz1 gene deletion by the TKnatCX targeting fragment generated using the tpz1 Top and Bot
100 base primer set (Table 1). 80–100 base of homologous sequences in the 100 base primer set targets 5’ and 3’ UTR regions of tpz1+ of one of
endogenous tpz1+ alleles. Replacement of tpz1+ by TKnatCX was confirmed by amplification of DNA fragment using diagnostic PCR primers, nat
F900 and tpz1 R400D. b Replacement of the TKnat cassette by the tpz1 mutant gene. The DNA fragment containing the promoter region and the
gene of tpz1+ was amplified using primers tpz1 F800U and R1745 and cloned between EcoO109I and NheI sites of pNX3a-HA3. The tpz1 gene was
mutated to generate K75A mutation using the sight-directed mutagenesis method. PvuII and PmeI digested tpz1(K75A)-3xHA:kanMX6 fragment
from pTpz1a4-K75A-HA3 can only recombine with TKnatCX deleted tpz1 allele, as right arm homology Ttef sequence is only present in the
TKnatCX cassette. c Integration of tpz1-K75A mutation and 3xHA tagging. Correct replacement was confirmed by amplification of DNA fragments
using diagnostic PCR primer sets, kan F800 and tpz1 R400D, and tpz1 F842U and Ptef R81 (or kan R276)
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Auxotrophic markers ura4+, leu1+, arg3+ and ade6+
were cloned from S. pombe genomic DNA using corre-
sponding primer sets listed in Table 6, and cloned into
pJET vector. To generate Cre-expression vectors with
various selection cassettes, auxotrophic markers leu1+,
arg3+, ura4+and ade6+ and drug selection markers Tka-
nAX, hygMX6, HyTkAX, natMX6, TKnatAX and aur1R
from the plasmid pAUR224 were amplified with primers
containing with BglII and PmeI sites and cloned into
pJET vector (ThermoFisher). The cloned cassettes were
digested with BglII and PmeI and replaced with kanMX6
of pNXRVa-HA3nls-Cre. For the systematic reason, the
drug resistant cassettes for G418, hygromycin B, clon-
Nat, and aureobasidin A and auxotrophic markers for
uracil, arginine, leucine, and adenine were assigned as ‘a’,
‘b’, ‘c’, ‘j’, ‘d’, ‘g’, ‘h’ and ‘k’, respectively. Through the cloning
process, we found point mutation (G201T) in the Zeocin
resistant gene that substitutes Tryptophan at the pos-
ition 67 to Cysteine (W67C), but the cassette retained
resistance to Zeocin (Fig. 1b).
The series of the C-terminal tagging plasmids, pNX3
was constructed as follows. The terminator of the S.
cerevisiae adh1 was cloned from the genomic DNA
using primers, Tscadh1 For-AscI and Tscadh1 R110-
BglII, and inserted into pNXRa after digestion with AscI
and BglII. ARS1 sequence was removed by digest of
pNXRa with EcoRI and AvrII and ligation following
Table 6 Oligos used for cloning and plasmid construction
Name Sequence
Pcmv top-PmeI atcatgaccggtttaaacCGTTACATAACTTACGGTAA
Pcmv top-BglII atcaccggtgctagcagatctcgcgaCGTTACATAAC
TTACGGTAA
Tsv40 bot-BglII atccctaggctgcagatctGCAGTGAAAAAAATGCTTTA
Tsv40 bot-PmeI agctgtacagatatcgagctcgtttaaacGCAGTGAAA
AAAATGCTTTA
Hyg top-HindIII atcctgaagcttacatgtccATGGGTAAAAAGCCTGA
ACTCACCGCGACG
Hyg bot-NheI-ClaI atcgattagctagcTACTTCTACACAGCCATCGGTCC
Tscleu2 top-ClaI-PstI atcgattagctgcagtAATCCTTGCTTAAAAAGATT
CTCT
Tscleu2 bot-PmeI agctgtacagatatcgagctcgtttaAACTCCATCAAAT
GGTCAGG
HSVtk top-SpeI-NcoI-
HIndIII
atcaagcttccatggaaactagtGCGTTCGACCAGGC
TGCGCGTT
HSVtk bot-XmaI-NcoI atcgattaacccatggccCGGGCAAACGTGCGCG
Padh1 top-PmeI tcaggcccttgaattcgtttaaacCCTACAACAACTAA
GAAAATGGCTATCATGCGGAAG
Padh1 bot-HindIII-NheI atcgctagcAAgcTTCTCTTGCTTAAAGAAAAGAA
AAGCGAAGGCACCTGTCCACCACCC
100 bp-bot GAATTCGAGCTCGTTTAAAC
Tscadh1 For-AscI tgaggCGCGCCACTTCTAAATAAGCG
Tscadh1 R110-BglII aagatctCCTAGCGGATCTGCCGGTAG
Amp rev CGACACGGAAATGTTGAATACTC
ori-AflIII CCTTTTGCTGGCCTTTTGCTCACAT
lox71-Padh1 top-BglII acggttaattaagatctaccgttcgtatagcatacattatacga
agttatactagtcatatgCCTACAACAACTAAGAAAA
TGGCTATCA
lox66-Ttef bot-PmeI atcgaattcgagctcgtttaaactaccgttcgtataatgtatg
ctatacgaagttataggcctaGGATGGCGGCGTTAG
TATCG
nls-Cre top-XbaI atttaattaactctagaTGTACTCCACCAAAGAAGA
AGAGAAAGGTTGCCcctagcATGGCCAATTTA
CTGACCGTACACCA
Cre bot-XbaI aggctagcggcgcgccTCAtctagaATCGCCATCTTC
CAGCAGGC
ura4 F530U-BglII ggcatagatctgagctcgatatcAAGCTTAGCTACAAA
TCCCACTGGCTATATGT
ura4 R190D-PmeI ttacctgagctcgtttaaacAAGCTTGTGATATTGACG
AAACTTTTTGACATCTAAT
leu1 F130U-BglII aagcttagatctCCATACGATATCCCAATCTGTAG
leu1 R200D-PmeI atcgagctcgtttaaacGGATGTCGTAAATCAATTC
CATGC
arg3 F130U-BglII aagatcTCGGCTATATGCAATCTCAC
arg3 R130D-PmeI aagtttaaacAGCCTGTGTCCTGCGCATA
ade6 F300U-BglII aagatcTAAGGTATAACGACAACAAACGTTGC
ade6 R150D-PmeI aagtttaaaCTGCTTCACAGCACATTATTCAGGAT
TCTT
aur1 F333U-BglII aagtcagcggcgcgccaagatctGTCAGGAAAGCTTT
TTTGCCTCT
aur1 R280D-PmeI agaattcgagctcgtttaaaCAAATACCTATACATCAC
ACTGGAA
Table 6 Oligos used for cloning and plasmid construction
(Continued)
3xHA top atccccgggttaattaacgctagcatgTACCCATACGAT
GTTCCTGACTATGCGGGCTACCCGTATGACGTG
CCGGACTATGCAGGAGCCTATCCTTATGACGTT
CCAGA
3xHA bot aggctagcggcgcgccTCAtctagaACCAGCGTAATC
TGGAACGTCATAAGGATAGGCTCCTGCATAGTC
CGGCACGTCATACGGGTAGCCCGCATAGTCAGG
AACATCG
3xPK-H6 top ggatccatatgTTAATTAACGCTAGCGGTAAGCCTA
TTCCTAACCCTCTTTTGGGTCTCGATTCTACAGG
TGGAAAACCAATCCCCAACCCACTCCTCGGCCT
TGACTCAACTGGCAAAC
3xPK-H6 bot agatctggcgcgcctaggatggtgatggtgatgatgtctaga
GGTACTATCTAATCCAAGTAAAGGATTTGGTATG
GGTTTGCCAGTTGAGTCAAGGCCGAGGAGTGGG
TTGGGGATTGG
3xFlag top taacgctagcatgGGTGACTACAAGGACGACGATG
ACAAGGGAGATTACAAAGATGACGACGATAA
GGACTACAAGGACGACGATGACAAGtctagaTG
Agg
3xFlag bot cgcgccTCAtctagaCTTGTCATCGTCGTCCTTGTAG
TCCTTATCGTCGTCATCTTTGTAATCTCCCTTGTC
ATCGTCGTCCTTGTAGTCACCcatgctagcgttaat
tpz1 F800U-PvuII-EcoO atcaggccctcagCTGTTCAGCACGGTACCAAG
tpz1 R1745-NheI gttgcagctagcGCTTTTGTTTCGAAACTCCTCTAT
Uppercase at 3’ end of oligo anneals to target and lowercase at 5’ end is a
linker containing restriction sites and additional sequence
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blunt ending of the cleaved sites. Unlike pFA6a C-tag
plasmids, this resulting plasmid, named pNX3a, lacks I-
SceI after Tadh1 and ClaI, EcoRV, SpeI, SfiI, NotI, SacII,
HpaI and SapI after kanMX6. To generate pNX3a-
HA3, the 3xHA fragment was produced by digest as
mentioned above and inserted into pNX3a following
PacI and AscI digest. Likewise, the three tandem PK
fragment (3xPK) was generated by annealing of oligos,
3xPK-H6 top and bot, followed by DNA polymerase re-
action. To generate pNX3a-PK3, the 3xPK fragment
was obtained by digest and replaced 3xHA of pNX3a-
HA3 after PacI-XbaI digest. Three tandem FLAG frag-
ment (3xFL) was generated by annealing of oligos,
3xFlag top and bot, followed by 5’ end phosphorylation.
To generate pNX3a-FL3, the 3xFL fragments were
inserted into pNX3a after PacI and AscI digest. The
kanMX6 cassette was replaced by other selection
markers using BglII and PmeI digest. All generated
plasmids for the C-terminus tagging are listed in
Table 5.
PCR amplification for gene targeting fragments
For amplification of the deletion fragments using pFA6a
series, the primer set (Top and Bot) was used. Top primer
is composed of 80–100 base forward sequence upstream
of the start codon of the target gene at the five prime end
and the vector annealing sequence CGGATCCCCGGGT-
TAATTAA at the three prime end. Bot primer is com-
posed of the complement sequence of downstream 80–
100 base sequence after the stop codon of the target gene
at the five prime end and vector annealing sequence
GAATTCGAGCTCGTTTAAAC at the three prime end.
For C-terminus tagging using pNX3 series, the C-tag
specific Tag primer and the deletion Bot primer were
used. The annealing sequence of Tag primer is the same
as Top primer for deletion but targeting sequence is 80–
100 base upstream from the end of the gene excluding
the stop codon. These oligos were synthesized by Inte-
grated DNA Technologies Inc. (IDT) using standard
desalting purification service. Details of primer design
have been described previously [2].
Three hundred microliter of PCR mixtures contained
30 μl of 10xbuffer I, 6 μl of 10 mM dNTPs and 1.5 μl of
long template polymerase mixture (Roche) with 0.75 μl
of pFA6a or pNX3 template vector (approximately
50–500 ng/μl, obtained using standard miniprep kit),
and 1.5 μl each of 100 μM primers. Premix was ali-
quoted into 50 μl and subjected to PCR [94 °C 30 sec,
50 °C 2 min, 68 °C 5 min for 5 cycles, followed by 94 °C
30 sec, 55 °C 1 min, 68 °C 5 min for 30 cycles, finishing
with 68 °C 10 min]. PCR products were combined, etha-
nol precipitated, and reconstituted in 10 μl of TE
(10 mM Tris–HCl 1 mM EDTA pH8.0).
PCR-based gene targeting
Fission yeast transformation was performed as described
[2] with minor changes. Logarithmically growing cells
~107 cells/ml (O.D600 = 0.5–0.8) were harvested, and
washed once with LiOAc solution (100 mM Lithium Acet-
ate pH7.5 in TE). Cell pellets were suspended in equal vol-
ume of LiOAc solution to make competent cells. 50 μl of
the competent cells were mixed with the gene targeting
PCR product, 130 μl of 40 % PEG solution (40 % of
PEG4000 in LiOAc solution) was added to the cells and
mixed gently by tapping. Cells were incubated at 32 °C for
1–4 h. After adding 21.5 μl of DMSO, and the cells were
heat-shocked at 42 °C for 5 min, precipitated briefly and
washed once with YES media. The transformed cells were
directly plated on EMM media for auxotrophic selection
or YES/EMM media for Aureobasidin B (TAKARA/Clon-
tech) selection. For other drug selection, transformed cells
were recovered in YES media for 4 h in shaking incubator
or overnight on the plate, and transferred to YES plate
containing G418 (FORMEDIUM), Zeocin (Invivogen),
Hygromycine B (FORMEDIUM and Roche) or ClonNat/
Nourseothricin (WERNER BioAgents). YES can be re-
placed with PMG media.
Cre-loxP counter selection
To remove loxP-flanked TK fusion cassette, cells were
transformed with any Cre expression vector (see transform-
ation procedure in previous section). After heat- shock
process, cells were directly plated on FdU containing YES
plate. FdU-resistant colonies were re-streaked on a fresh
FdU plate to isolate a single colonies. Loss of TK fusion cas-
sette and the Cre expression vector were confirmed by sen-
sitivity to the drugs. Alternatively, pNXRVj-HACre was
used for Cre expression, the transformants carrying Cre
vector were selected by resistance to aureobasidin B. The
resistant colonies were re-streaked on YES plates, and col-
onies that lost the drug resistance were isolated.
Southern blot
Telomere Southern blotting was performed as described
previously [28]. Genomic DNA was prepared 2 weeks after
generation of the strains unless indicated. Equal amounts of
EcoRI digested DNA fragments were separated on a 1 %
agarose gel and subjected to Southern blotting with a
telomere probe.
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